
|Articles|September 18, 2014
- Melanoma (Issue 3)
- Volume 3
- Issue 1
Immunotherapy Combinations for the Treatment of Melanoma
Author(s)Mario Sznol, MD
Mario Sznol, MD, professor, Internal Medicine, Yale Cancer Center, discusses the potential for immunotherapy combinations for the treatment of melanoma.
Advertisement
Mario Sznol, MD, professor, Internal Medicine, Yale Cancer Center, discusses the potential for immunotherapy combinations for the treatment of melanoma.
Read about checkpoint strategies for the treatment of melanoma > >
Articles in this issue
about 11 years ago
Inducing an Immune Response With a Patient’s Tumorabout 11 years ago
Partnering T-VEC With a Targeted Agent for the Treatment of MelanomaAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































